| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0053 | 1 |